Entering text into the input field will update the search result below

Spark Therapeutics (ONCE) CEO Jeff Marrazzo on Q2 2018 Results - Earnings Call Transcript

Aug. 07, 2018 3:27 PM ETRoche Holding AG (RHHBY)
SA Transcripts profile picture
SA Transcripts

Start Time: 08:30 January 1, 0000 9:33 AM ET

Spark Therapeutics (ONCE)

Q2 2018 Earnings Conference Call

August 07, 2018, 08:30 AM ET


Jeff Marrazzo - CEO

Kathy High - President and Head of R&D

Stephen Webster - CFO

John Furey - COO

Ryan Asay - Head, IR


Phil Nadeau - Cowen and Company

Martin Auster - Credit Suisse

Gena Wang - Barclays Capital

Cory Kasimov - JPMorgan

Michael Yee - Jefferies

Mohit Bansal - Citigroup

Raju Prasad - William Blair

Vincent Chen - Bernstein

Steven Breazzano - Evercore ISI

Matthew Luchini - BMO Capital Markets

Elemer Piros - Cantor Fitzgerald


Good day, ladies and gentlemen, and welcome to the Q2 2018 Spark Therapeutics, Inc. Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions]. As a reminder, this conference is being recorded.

I would now like to introduce your host for today's conference, Ryan Asay, Head of Investor Relations. You may begin.

Ryan Asay

Thank you, Gigi. Welcome everyone to the Spark Therapeutics second quarter 2018 conference call. With me today from the company are Jeff Marrazzo, Chief Executive Officer; Dr. Kathy High, President and Head of Research and Development; John Furey, Chief Operating Officer; and Stephen Webster, Chief Financial Officer.

Please note that this conference call will include forward-looking statements regarding our products, programs and product candidates. Because such statements deal with future events and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements. For a full discussion of these risks and uncertainties, please review our annual report on Form 10-K and our quarterly report on Form 10-Q that are filed with the U.S. Securities and Exchange Commission.

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.